MIM
CGON icon

MetLife Investment Management’s CG Oncology CGON Stock Holding History

MetLife Investment Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.21M Buy
32,604
+256
+0.8% +$14.5K 0.01% 1011
2025
Q4 		$1.34M Sell
32,348
-1,241
-4% -$51.4K 0.01% 1274
2025
Q3 		$1.35M Hold
33,589
– – 0.01% 1290
2025
Q2 		$873K Buy
33,589
+1,774
+6% +$42.8K 0.01% 1377
2025
Q1 		$779K Buy
31,815
+2,789
+10% +$78.5K ﹤0.01% 1487
2024
Q4 		$832K Buy
29,026
+1,894
+7% +$64.8K ﹤0.01% 1511
2024
Q3 		$1.02M Buy
27,132
+13,780
+103% +$483K 0.01% 1378
2024
Q2 		$422K Buy
13,352
+1,246
+10% +$43.2K ﹤0.01% 1820
2024
Q1 		$531K Buy
+12,106
New +$494K ﹤0.01% 1638

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

MetLife Investment Management's CGON Position: Q1 2026 in Review

MetLife Investment Management increased its CG Oncology (CGON) stake by 0.79% in Q1 2026, buying an estimated $14.5K and bringing the position to 32,604 shares worth $2.21M. The position accounts for 0.01% of the portfolio, ranked #1011.

MetLife Investment Management first reported a position in CGON in Q1 2024 and has held it in 9 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • MetLife Investment Management held 32,604 shares of CG Oncology worth $2.21M as of Q1 2026.
  • MetLife Investment Management bought 256 CG Oncology shares in Q1 2026, an estimated $14.5K.
  • CG Oncology made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1011 holding.
  • MetLife Investment Management first reported a position in CG Oncology in Q1 2024 and has held it in 9 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.